NCT06390410View on ClinicalTrials.gov

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

December 7, 2024

Study Completion Date

December 7, 2024

Conditions
Hepatic Insufficiency
Interventions
DRUG

Simufilam

100 mg PTI-125

Trial Locations (3)

32809

Orlando Clinical Research Center, Orlando

33014

Clinical Pharmacology of Miami, Miami

92630

Orange County Research Center, Lake Forest

Sponsors
All Listed Sponsors
lead

Cassava Sciences, Inc.

INDUSTRY

NCT06390410 - A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function | Biotech Hunter | Biotech Hunter